Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Fred Mussler who wrote (351)	9/24/1998 11:24:00 AM
From: Marty	Read Replies (1) \| Respond to of 857

If you want to hear what the company is doing about this attack on the stock price, listen to this conference call. This is a copy of a post on the Yahoo message board on HEB. ------------------------------------------------ Call 800-475-6701 CODE : 408590 The complete 2 1/2 hours of the conference will be available for the next 30 days. DON'T MISS IT!!! Dr. Carter at his very best. What a great company. ----------------------------------------------- It seems that the AMEX and the SEC have a task force in place checking on those illegally shorting the stock without actually borrowing it. Dr. Carter and other biotech experts are in on the call and respond, point by point, to Asensio's allegations. It turns out that Asensio's allegations are either outright false, ancient, irrelevant, or only partially true (with the positive part omitted). What Asensio did was to point out old problems that came up 10 years ago and neglect to mention that they have long since been resolved. Problems the brokerage house may have had later had absolutely nothing to do with HEB. One brokerage house (or it may have been BioVest, who covers the stock and the technology) in on the conference call reiterated their HEB target price of 50 (!). HEB is also suing Asensio. IMHO, once the truth is out and Asensio tactics finally exposed, there will be a text book short squeeze as shorters will rush to buy to cover their shorts.